News

CEVEC Pharmaceuticals GmbH announced the signing of an agreement with UCB S.A. on the evaluation and use of CEVEC’s proprietary ELEVECTA® Technology for the research, development, and manufacturing of Adeno-Associated Virus (AAV) vectors for gene therapy applications. According to the...

Arecor Therapeutics plc, a biopharmaceutical group advancing therapies to enable healthier lives, has signed a formulation agreement with Intas Pharmaceuticals Ltd. Under this agreement, Arecor will use its proprietary formulation technology platform Arestat to develop a differentiated product for Intas....

DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal. Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s...

Indian drug developer Hetero said it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's (ROG.S) COVID-19 drug. Hetero expects to make the treatment, tocilizumab, available in India by the...

Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its Covid-19 vaccine with some conditions. This trial will assess the safety, tolerability and immunogenicity of the...

Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC™) for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS) in Brazil....

Dr.Reddy's Laboratories rose 0.71% to Rs 4934 after the company signed a deal with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox). In an exchange filing made on Saturday (4 September 2021), the drug maker...